About PolyAdvant
Igniting Hope in Cancer Treatment
Pioneering Precision Radiotherapy and Chemotherapy
PolyAdvant is at the forefront of cancer treatment, dedicated to exploring the boundaries of oncology care. With a large market demand and an urgent need for efficient, low toxicity treatments to increase the sensitivity of radiotherapy, we are engaged in the research and development of anti-tumor drugs that can revolutionize the global precision radiotherapy and chemotherapy field.
Our Vision and Mission
Our vision is to bring light to the lives of cancer patients by enhancing the efficacy of radiotherapy through precision medicine. Our mission is to become a pioneer in the activation of anticancer prodrugs through radiotherapy, accurately releasing and killing tumor cells locally, thus enhancing the efficacy of radiotherapy and opening up a new field of precise synchronous radiotherapy and chemotherapy.